What happened to 23andMe? Here's a look at its history from launch to bankruptcy and acquisition by Regeneron.

Regeneron, a biotech company, will acquire 23andMe for $256 million and vowed to comply with the genetic testing company's privacy policies.

Regeneron Pharmaceuticals said it would acquire 23andMe, which filed for bankruptcy in March and would continue to offer consumer DNA testing services.

Genetic testing company 23andMe is being acquired, shortly after it declared bankruptcy months ago.

Being spliced on to Regeneron will free the genetic testing company from its fatal dependence on sporadic revenue

CHARLOTTE — North Carolinians can file claims against genetic testing company 23andMe for the 2023 data breach until July 14. A release from the North Carolina Attorney General Tuesday said those who are eligible to file must meet the following requirements: You were a 23andMe customer between May 1, 2023, and October 1, 2023.

Your 23andMe data is getting a new owner — so what are your options moving forward? The DNA testing company announced on Monday that its assets are being acquired by Regeneron Pharmaceuticals. The sale renewed concerns from some customers online about their data and how its new owner plans to use it.